Jonas Göran Ekblom
Director/Board Member at COMBIGENE AB
Profile
Jonas Göran Ekblom is the founder of Anaborex, Inc. He currently holds several positions, including Chairman at EffRx Pharmaceuticals SA since 2016, Director at Pergamum AB since 2010, Director at CombiGene AB since 2020, Director at World 5 Ventures since 2020, Director at Pergasus AB, and Associate Professor at the University of Uppsala.
In the past, he served as President & Chief Executive Officer at Promore Pharma AB, Chief Executive Officer at BOWS Pharmaceuticals AG, Chairman at Axelar AB from 2015 to 2019, Director at KLIFO A from 2011 to 2017, Director at The Releef Initiative from 2004 to 2018, Principal at Pharmacia AB, Chief Operating Officer at Nanostream, Inc., Principal at Biovitrum AB, Principal at Invitrogen AB, and Principal at Sequenom GmbH.
He obtained a doctorate degree from the University of Uppsala, an undergraduate degree from the University of Stockholm, and a doctorate degree from USC School of Pharmacy.
Jonas Göran Ekblom active positions
| Companies | Position | Start |
|---|---|---|
| COMBIGENE AB | Director/Board Member | 2019-12-31 |
| Edge of The World Strategies Corp. | President | 2006-12-31 |
| World 5 Ventures | Director/Board Member | 2019-12-31 |
EffRx Pharmaceuticals SA
 EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Chairman | 2015-12-31 |
| University of Uppsala | Corporate Officer/Principal | - |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Director/Board Member | 2014-12-31 |
| Pergasus AB | Director/Board Member | - |
Former positions of Jonas Göran Ekblom
| Companies | Position | End |
|---|---|---|
Axelar AB
 Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Chairman | 2018-12-31 |
| The Releef Initiative | Director/Board Member | 2017-12-31 |
| ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Jonas Göran Ekblom
| University of Uppsala | Doctorate Degree |
| University of Stockholm | Undergraduate Degree |
| USC School of Pharmacy | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| COMBIGENE AB | Health Technology |
| Private companies | 16 |
|---|---|
Anaborex, Inc.
 Anaborex, Inc. Medical/Nursing ServicesHealth Services Anaborex, Inc. provides clinical research services for metabolic diseases. The company develops drugs for the treatment of cancer related wasting syndrome. It was founded in 2005 by Alan Saven and Jorge Nieva and is located in La Jolla, CA | Health Services |
EffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Health Technology |
| Pharmacia AB | Health Technology |
Nanostream, Inc.
 Nanostream, Inc. BiotechnologyHealth Technology Nanostream, Inc. provides microfluidic analytical systems. The company develops microfluidic systems to automate routine laboratory procedures that are critical to research productivity. It furnishes the miniaturized plumbing critical to the future of pharmaceutical sciences. Nanostream was founded in 1999 and is headquartered in Pasadena, CA. | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Axelar AB
Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
| Invitrogen AB | |
BOWS Pharmaceuticals AG
 BOWS Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services BOWS Pharmaceuticals AG operates as a biotechnology firm. The company is headquartered in Zug, Switzerland. | Commercial Services |
Sequenom GmbH
 Sequenom GmbH Medical SpecialtiesHealth Technology Part of Laboratory Corp. of America Holdings, Sequenom GmbH is a German company that manufactures computer applications and technology systems for the diagnostic of genomic sciences. The private company is based in Hamburg, Germany. | Health Technology |
| The Releef Initiative | |
| World 5 Ventures | |
| Edge of The World Strategies Corp. | |
| Pergasus AB |
- Stock Market
- Insiders
- Jonas Göran Ekblom
